PortfoliosLab logoPortfoliosLab logo
ESIH.DE vs. ETLI.DE
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

ESIH.DE vs. ETLI.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ESIH.DE vs. ETLI.DE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ESIH.DE
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
0.03%7.95%4.09%7.63%-4.59%25.93%-0.69%
ETLI.DE
L&G Pharma Breakthrough UCITS ETF
1.66%22.23%0.42%-12.64%-2.91%4.98%2.91%

Returns By Period

In the year-to-date period, ESIH.DE achieves a 0.03% return, which is significantly lower than ETLI.DE's 1.66% return.


ESIH.DE

1D
0.18%
1M
-2.64%
YTD
0.03%
6M
5.22%
1Y
7.68%
3Y*
5.25%
5Y*
7.40%
10Y*

ETLI.DE

1D
-0.13%
1M
4.34%
YTD
1.66%
6M
7.84%
1Y
24.29%
3Y*
4.93%
5Y*
2.33%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ESIH.DE vs. ETLI.DE - Expense Ratio Comparison

ESIH.DE has a 0.18% expense ratio, which is lower than ETLI.DE's 0.49% expense ratio.


Return for Risk

ESIH.DE vs. ETLI.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESIH.DE
ESIH.DE Risk / Return Rank: 2222
Overall Rank
ESIH.DE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
ESIH.DE Sortino Ratio Rank: 2121
Sortino Ratio Rank
ESIH.DE Omega Ratio Rank: 2121
Omega Ratio Rank
ESIH.DE Calmar Ratio Rank: 2323
Calmar Ratio Rank
ESIH.DE Martin Ratio Rank: 2222
Martin Ratio Rank

ETLI.DE
ETLI.DE Risk / Return Rank: 6666
Overall Rank
ETLI.DE Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
ETLI.DE Sortino Ratio Rank: 6060
Sortino Ratio Rank
ETLI.DE Omega Ratio Rank: 5454
Omega Ratio Rank
ETLI.DE Calmar Ratio Rank: 8282
Calmar Ratio Rank
ETLI.DE Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESIH.DE vs. ETLI.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ESIH.DEETLI.DEDifference

Sharpe ratio

Return per unit of total volatility

0.40

1.16

-0.76

Sortino ratio

Return per unit of downside risk

0.67

1.62

-0.96

Omega ratio

Gain probability vs. loss probability

1.09

1.21

-0.12

Calmar ratio

Return relative to maximum drawdown

0.68

2.91

-2.23

Martin ratio

Return relative to average drawdown

2.02

8.83

-6.81

ESIH.DE vs. ETLI.DE - Sharpe Ratio Comparison

The current ESIH.DE Sharpe Ratio is 0.40, which is lower than the ETLI.DE Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of ESIH.DE and ETLI.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ESIH.DEETLI.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.40

1.16

-0.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

0.14

+0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

0.24

+0.21

Correlation

The correlation between ESIH.DE and ETLI.DE is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

ESIH.DE vs. ETLI.DE - Dividend Comparison

Neither ESIH.DE nor ETLI.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ESIH.DE vs. ETLI.DE - Drawdown Comparison

The maximum ESIH.DE drawdown since its inception was -26.69%, smaller than the maximum ETLI.DE drawdown of -30.83%. Use the drawdown chart below to compare losses from any high point for ESIH.DE and ETLI.DE.


Loading graphics...

Drawdown Indicators


ESIH.DEETLI.DEDifference

Max Drawdown

Largest peak-to-trough decline

-26.69%

-30.83%

+4.14%

Max Drawdown (1Y)

Largest decline over 1 year

-12.82%

-12.16%

-0.66%

Max Drawdown (5Y)

Largest decline over 5 years

-26.69%

-30.83%

+4.14%

Current Drawdown

Current decline from peak

-8.80%

-1.49%

-7.31%

Average Drawdown

Average peak-to-trough decline

-7.14%

-10.37%

+3.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.30%

3.18%

+1.12%

Volatility

ESIH.DE vs. ETLI.DE - Volatility Comparison

The current volatility for iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) (ESIH.DE) is 4.91%, while L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a volatility of 7.39%. This indicates that ESIH.DE experiences smaller price fluctuations and is considered to be less risky than ETLI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ESIH.DEETLI.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.91%

7.39%

-2.48%

Volatility (6M)

Calculated over the trailing 6-month period

10.33%

13.79%

-3.46%

Volatility (1Y)

Calculated over the trailing 1-year period

19.20%

20.89%

-1.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.59%

17.01%

-1.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.45%

18.87%

-3.42%